Reply
- PMID: 33027114
- DOI: 10.1097/HJH.0000000000002602
Reply
Comment on
-
2020 International Society of Hypertension global hypertension practice guidelines.J Hypertens. 2020 Jun;38(6):982-1004. doi: 10.1097/HJH.0000000000002453. J Hypertens. 2020. PMID: 32371787 No abstract available.
-
2020 International Society of Hypertension Guidelines: preference of calcium channel blocker over thiazide-like diuretics lacks evidence.J Hypertens. 2020 Nov;38(11):2335-2336. doi: 10.1097/HJH.0000000000002601. J Hypertens. 2020. PMID: 33027113 No abstract available.
References
-
- Pareek A, Ram CVS, Joshi S, Mehta RT. 2020 International Society of Hypertension Guidelines: preference of calcium channel blocker over thiazide-like diuretics lacks evidence. J Hypertens 2020; 38:???–???.
-
- Jamerson K, Weber MA, Bakris GL, Dahlof B, Pitt B, Shi V, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008; 359:2417–2428.
-
- Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J 2018; 39:3021–3104.
-
- Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension 2020; 75:1334–1357. and J Hypertens 2020; 38:982–1004.
-
- Dahlof B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, et al. Prospective Studies CollaborationPrevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005; 366:895–906.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources